Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acid esters
Reexamination Certificate
2006-05-23
2006-05-23
Richter, Joanne (Department: 1614)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acid esters
C560S174000, C560S129000
Reexamination Certificate
active
07049461
ABSTRACT:
A preferred embodiment of the invention encompasses a compounds having the property of anti-carcinogenic activity against human leukemia comprising the use of 4-(4-Ethoxy-phenyl)-2-(N′-fluoren-9-ylidene-hydrazino)-2-hydroxy-4-oxo-butyric acid methyl ester (OF-13), and/or 4-Chloro-4-(4-ethoxy-phenyl)-2-(fluoren-9-ylidene-hydrazono)-but-3-enoic acid methyl ester (3F-19) in humans as therapeutic means for the eradication of leukemia from the human's body.
REFERENCES:
patent: 5308852 (1994-05-01), Girard
patent: 5334612 (1994-08-01), Kalden
patent: 6048896 (2000-04-01), Giordani
patent: 6066670 (2000-05-01), Brown
patent: 6121450 (2000-09-01), Jones
patent: 6180651 (2001-01-01), Nicolai
patent: 6232312 (2001-05-01), Pamukcu
Korotkova Tatiana A.
Miles D. Howard
Petrovna Krasnykh Olga
Vladmirovitch Malanin Vladimir
Yurjevich Solodnikov Sergey
Dexter Roland
Law Offices of Brian S. Steinberger , P.A.
Puttlitz Karl
Richter Joanne
Steinberger Brian S.
LandOfFree
Treatment of leukemia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of leukemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of leukemia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3542184